Subscribe To
Uaw defers expanding its strike as 'new phase' makes surprise walkouts the norm
The United Auto Workers (UAW) held off on expanding its strike on Friday, warning it will no longer be announcing strikes in advance and is prepared t...
October 13, 2023, 1:01 pm
Enphase: long-term technical support despite macro headwinds (technical analysis)
Enphase Energy is a key player in the clean energy sector, specializing in batteries and microinverters...
October 13, 2023, 11:56 am
Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting
IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...
October 13, 2023, 11:00 am
Shopify: riding high on promising future growth
Shopify Inc.'s strong market position and growth potential are evident. Concerns arise regarding the recent valuation as Shopify enters a more mature ...
October 13, 2023, 10:26 am
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) ...
October 13, 2023, 10:22 am
Enphase (enph) ventures into the solar market of south africa
Enphase (ENPH) enters the solar market of South Africa by unveiling its IQ8 Microinverters for resident...
October 13, 2023, 9:46 am
Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
October 13, 2023, 9:05 am
Abbvie's (abbv) rinvoq meets key goal in phase ii vitiligo study
AbbVie (ABBV) meets the primary goal in the phase II study evaluating Rinvoq in the treatment of adult ...
October 13, 2023, 8:16 am
This ultra-high-yielding dividend stock continues to take steps to get healthy again
Medical Properties Trust recently closed the second phase of its Australian hospital sale. It also boug...
October 13, 2023, 5:16 am
Fed's collins: bond yield rise likely reduces need for near-term fed hike
Fed is at or near the rate hiking cycleToo soon to take prospect of additional hike off the tableBond yield rise likely reduces need for near-term Fed...
October 12, 2023, 8:00 pm
Why scholar rock holding stock soared today
Scholar Rock announced it will advance the development of its obesity treatment, SRK-439, starting with a phas...
October 12, 2023, 4:17 pm
Biocardia (bcda) up on plans for second heart failure study
BioCardia (BCDA) completes enrollment in a pivotal phase III study on its CardiAMP cell therapy for the...
October 12, 2023, 12:47 pm
Incyte (incy) posts upbeat data from phase ii vitiligo study
Incyte (INCY) announces new positive 52-week data from its mid-stage study of povorcitinib for the treatment of adult patients with extensive nonsegme...
October 12, 2023, 12:47 pm
Pfizer's lung cancer combination therapy approved by the fda
Pfizer Inc (NYSE:PFE) announced that the United States Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) plus MEKTOVI (binimetin...
October 12, 2023, 8:41 am
Jaguar health to present october 17 at the lytham partners fall 2023 investor conference and october 18 at the bio investor forum
Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for pr...
October 12, 2023, 8:30 am
Gbp/usd forecast: next hurdle for pound sterling aligns at 1.2360
GBP/USD struggled to preserve its bullish momentum early Thursday and went into a consolidation phase a...
October 12, 2023, 8:14 am
Eli lilly: the glp-1 opportunity, while increasingly recognized, is vastly underestimated
Eli Lilly is expected to receive FDA approval for tirzepatide, an obesity medication, and has two other medications in ...
October 11, 2023, 5:33 pm
Wall street warms up to tempest as tpst stock surges 1,500%
Tempest Therapeutics (NASDAQ: TPST ) is the stock to watch for today, as its shares are up by a staggering 1,500%. This morning, the cancer therapies ...
October 11, 2023, 12:54 pm
Ventyx (vtyx) down despite positive ulcerative colitis study data
Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipelin...
October 11, 2023, 12:47 pm
Conduit pharmaceuticals partners with clinconnect on cocrystal development program for azd1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed ...
October 11, 2023, 12:30 pm